Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Statin Therapy and Survival among Women with Ovarian Cancer: how much of it Is True?

Mormile R.

Pathol Oncol Res. 2019 Aug 17. doi: 10.1007/s12253-019-00729-7. [Epub ahead of print] No abstract available.

PMID:
31420840
2.

Statin treatment is associated with survival in a nationally representative population of elderly women with epithelial ovarian cancer.

Vogel TJ, Goodman MT, Li AJ, Jeon CY.

Gynecol Oncol. 2017 Aug;146(2):340-345. doi: 10.1016/j.ygyno.2017.05.009. Epub 2017 Jun 7.

PMID:
28596017
3.

Use of Statin Medications Following Diagnosis in Relation to Survival among Women with Ovarian Cancer.

Harding BN, Delaney JA, Urban RR, Weiss NS.

Cancer Epidemiol Biomarkers Prev. 2019 Jul;28(7):1127-1133. doi: 10.1158/1055-9965.EPI-18-1194. Epub 2019 May 7.

PMID:
31064757
4.

Statin use is associated with improved survival in ovarian cancer: A retrospective population-based study.

Couttenier A, Lacroix O, Vaes E, Cardwell CR, De Schutter H, Robert A.

PLoS One. 2017 Dec 19;12(12):e0189233. doi: 10.1371/journal.pone.0189233. eCollection 2017.

5.

Statin use and mortality among ovarian cancer patients: A population-based cohort study.

Verdoodt F, Kjaer Hansen M, Kjaer SK, Pottegård A, Friis S, Dehlendorff C.

Int J Cancer. 2017 Jul 15;141(2):279-286. doi: 10.1002/ijc.30738. Epub 2017 May 8.

6.

Statin use and female reproductive organ cancer risk in a large population-based setting.

Yu O, Boudreau DM, Buist DS, Miglioretti DL.

Cancer Causes Control. 2009 Jul;20(5):609-16. doi: 10.1007/s10552-008-9271-1. Epub 2008 Nov 30.

7.

Statin use and the risk of ovarian and endometrial cancers: a meta-analysis.

Wang Y, Ren F, Song Z, Chen P, Liu S, Ouyang L.

BMC Cancer. 2019 Jul 24;19(1):730. doi: 10.1186/s12885-019-5954-0.

8.

Oxysterols synergize with statins by inhibiting SREBP-2 in ovarian cancer cells.

Casella C, Miller DH, Lynch K, Brodsky AS.

Gynecol Oncol. 2014 Nov;135(2):333-41. doi: 10.1016/j.ygyno.2014.08.015. Epub 2014 Aug 16.

9.

Statin use and risk for ovarian cancer: a Danish nationwide case-control study.

Baandrup L, Dehlendorff C, Friis S, Olsen JH, Kjær SK.

Br J Cancer. 2015 Jan 6;112(1):157-61. doi: 10.1038/bjc.2014.574. Epub 2014 Nov 13.

10.

An analysis of the association between statin use and risk of endometrial and ovarian cancers in the Women's Health Initiative.

Desai P, Wallace R, Anderson ML, Howard BV, Ray RM, Wu C, Safford M, Martin LW, Rohan T, Manson JE, Simon MS.

Gynecol Oncol. 2018 Mar;148(3):540-546. doi: 10.1016/j.ygyno.2018.01.006. Epub 2018 Feb 13.

11.

Statin as a Combined Therapy for Advanced-Stage Ovarian Cancer: A Propensity Score Matched Analysis.

Chen HY, Wang Q, Xu QH, Yan L, Gao XF, Lu YH, Wang L.

Biomed Res Int. 2016;2016:9125238. Epub 2016 Nov 16.

12.

Statin therapy and association with ovarian cancer risk in the New England Case Control (NEC) study.

Akinwunmi B, Vitonis AF, Titus L, Terry KL, Cramer DW.

Int J Cancer. 2019 Mar 1;144(5):991-1000. doi: 10.1002/ijc.31758. Epub 2018 Oct 30.

PMID:
30006925
13.

Impact of postdiagnostic statin use on ovarian cancer mortality: A systematic review and meta-analysis of observational studies.

Li X, Zhou J.

Br J Clin Pharmacol. 2018 Jun;84(6):1109-1120. doi: 10.1111/bcp.13559. Epub 2018 Apr 2.

14.

Statin therapy is associated with improved survival in patients with non-serous-papillary epithelial ovarian cancer: a retrospective cohort analysis.

Habis M, Wroblewski K, Bradaric M, Ismail N, Yamada SD, Litchfield L, Lengyel E, Romero IL.

PLoS One. 2014 Aug 13;9(8):e104521. doi: 10.1371/journal.pone.0104521. eCollection 2014.

15.

Differences in discontinuation of statin treatment in women and men with advanced cancer disease.

Bergström H, Brånvall E, Helde-Frankling M, Björkhem-Bergman L.

Biol Sex Differ. 2018 Oct 20;9(1):47. doi: 10.1186/s13293-018-0207-5.

16.

Effect of statin on risk of gynecologic cancers: a meta-analysis of observational studies and randomized controlled trials.

Liu Y, Qin A, Li T, Qin X, Li S.

Gynecol Oncol. 2014 Jun;133(3):647-55. doi: 10.1016/j.ygyno.2014.04.007. Epub 2014 Apr 13.

PMID:
24736024
17.

Acupuncture for polycystic ovarian syndrome.

Lim CE, Ng RW, Xu K, Cheng NC, Xue CC, Liu JP, Chen N.

Cochrane Database Syst Rev. 2016 May 3;(5):CD007689. doi: 10.1002/14651858.CD007689.pub3. Review. Update in: Cochrane Database Syst Rev. 2019 Jul 02;7:CD007689.

PMID:
27136291
18.

Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer.

Jaaback K, Johnson N, Lawrie TA.

Cochrane Database Syst Rev. 2016 Jan 12;(1):CD005340. doi: 10.1002/14651858.CD005340.pub4. Review.

PMID:
26755441
19.

Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer.

Jaaback K, Johnson N, Lawrie TA.

Cochrane Database Syst Rev. 2011 Nov 9;(11):CD005340. doi: 10.1002/14651858.CD005340.pub3. Review. Update in: Cochrane Database Syst Rev. 2016;1:CD005340.

20.

Statin use and all-cancer survival: prospective results from the Women's Health Initiative.

Wang A, Aragaki AK, Tang JY, Kurian AW, Manson JE, Chlebowski RT, Simon M, Desai P, Wassertheil-Smoller S, Liu S, Kritchevsky S, Wakelee HA, Stefanick ML.

Br J Cancer. 2016 Jun 28;115(1):129-35. doi: 10.1038/bjc.2016.149. Epub 2016 Jun 9.

Supplemental Content

Support Center